144 related articles for article (PubMed ID: 34954640)
1. Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort.
Salto-Alejandre S; Palacios-Baena ZR; Arribas JR; Berenguer J; Carratalà J; Jarrín I; Ryan P; Miguel-Montero M; Rodríguez-Baño J; Pachón J;
Biomed Pharmacother; 2022 Feb; 146():112572. PubMed ID: 34954640
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study.
Li H; Xiong N; Li C; Gong Y; Liu L; Yang H; Tan X; Jiang N; Zong Q; Wang J; Lu Z; Yin X
Int J Infect Dis; 2021 Mar; 104():641-648. PubMed ID: 33515771
[TBL] [Abstract][Full Text] [Related]
3. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
[TBL] [Abstract][Full Text] [Related]
4. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
5. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and laboratory findings on admission to the emergency department among 2873 hospitalized patients with COVID-19: the impact of adjusted laboratory tests in multicenter studies. A multicenter study in Spain (BIOCOVID-Spain study).
García de Guadiana-Romualdo L; Morell-García D; Morales-Indiano C; Bauça JM; Alcaide Martín MJ; Esparza Del Valle C; Gutiérrez Revilla JI; Urrechaga E; Álamo JM; Hernando Holgado AM; Lorenzo-Lozano MC; Sánchez Fdez-Pacheco S; de la Hera Cagigal P; Juncos Tobarra MA; Vílchez JA; Vírseda Chamorro I; Gutiérrez Garcia I; Pastor Murcia Y; Sahuquillo Frías L; Altimira Queral L; Nuez-Zaragoza E; Adell Ruiz de León J; Ruiz Ripa A; Salas Gómez-Pablos P; Cebreiros López I; Fernández Uriarte A; Larruzea Á; López Yepes ML; Esteban Torrella P; Zamorano Andrés MC; Pedregosa Díaz J; Acevedo Alcaraz C; Blazquez-Manzanera AL; Padilla Jiménez AML; Baamonde Calzada MC; Vera M; Cháfer Rudilla M; Canalda Campás M; García Muñoz S; Vicente Gutiérrez L; Jiménez Añón L; Pérez Martínez A; Pons Castillo A; González Tamayo R; Férriz Vivancos J; Rodríguez-Fraga O; Ferrer Díaz de Brito Fernández V; Aguadero V; García Arévalo MG; Arnaldos Carrillo M; González Morales M; Núñez Gárate M; Ruiz Iruela C; Sancho-Rodríguez N; Vila Pérez M; Egea-Caparrós JM; Sáenz L; Blasco Barbero Á; Galán Ortega A
Scand J Clin Lab Invest; 2021 May; 81(3):187-193. PubMed ID: 33591234
[TBL] [Abstract][Full Text] [Related]
8. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients.
Duarte-Millán MA; Mesa-Plaza N; Guerrero-Santillán M; Morales-Ortega A; Bernal-Bello D; Farfán-Sedano AI; García de Viedma-García V; Velázquez-Ríos L; Frutos-Pérez B; De Ancos-Aracil CL; Soria Fernández-Llamazares G; Toledano-Macías M; Cristóbal-Bilbao R; Luquín-Ciuro N; Marrero-Francés J; Piedrabuena-García SI; Satué-Bartolomé JA; Gonzalo-Pascua S; Rivilla-Jiménez M; Carpintero-García L; Ayala-Larrañaga I; García-Bermúdez V; Lara-Montes C; Llerena-Riofrío ÁR; RIvas-Prado L; Walter S; Escriba-Barcena A; San Martín López JV; Ruíz-Giardín JM
J Med Virol; 2022 Apr; 94(4):1540-1549. PubMed ID: 34845754
[TBL] [Abstract][Full Text] [Related]
10. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
Rodriguez-Gonzalez CG; Chamorro-de-Vega E; Valerio M; Amor-Garcia MA; Tejerina F; Sancho-Gonzalez M; Narrillos-Moraza A; Gimenez-Manzorro A; Manrique-Rodriguez S; Machado M; Olmedo M; Escudero-Vilaplana V; Villanueva-Bueno C; Torroba-Sanz B; Melgarejo-Ortuño A; Vicente-Valor J; Herranz A; Bouza E; Muñoz P; Sanjurjo M
Int J Antimicrob Agents; 2021 Feb; 57(2):106249. PubMed ID: 33259918
[TBL] [Abstract][Full Text] [Related]
12. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
[TBL] [Abstract][Full Text] [Related]
13. Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study.
de Abajo FJ; Rodríguez-Miguel A; Rodríguez-Martín S; Lerma V; García-Lledó A;
BMC Med; 2021 May; 19(1):118. PubMed ID: 33980231
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study.
A Malhani A; A Enani M; Saheb Sharif-Askari F; R Alghareeb M; T Bin-Brikan R; A AlShahrani S; Halwani R; Tleyjeh IM
PLoS One; 2021; 16(6):e0252984. PubMed ID: 34111191
[TBL] [Abstract][Full Text] [Related]
16. Study of the effects of interferon β-1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study.
Fallahzadeh M; Pourhoseingholi MA; Boroujeni MG; Besharati S; Mardani M; Shabani M; Shokouhi S; Amirdosara M; Hajiesmaeili M; Gachkar L; Roshan B; Zangi M; Mirmomeni G; Irvani SSN; Alavi Darazam I
J Med Virol; 2022 Apr; 94(4):1488-1493. PubMed ID: 34821387
[TBL] [Abstract][Full Text] [Related]
17. Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.
Abizanda P; Calbo Mayo JM; Mas Romero M; Cortés Zamora EB; Tabernero Sahuquillo MT; Romero Rizos L; Sánchez-Jurado PM; Sánchez-Nievas G; Campayo Escolano C; Ochoa Serrano A; Sánchez-Flor Alfaro V; López Bru R; Gómez Ballesteros C; Caldevilla Bernardo D; Callejas González FJ; Andrés-Pretel F; Lauschke VM; Stebbing J
J Am Geriatr Soc; 2021 Oct; 69(10):2752-2758. PubMed ID: 34235720
[TBL] [Abstract][Full Text] [Related]
18. A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.
Doi Y; Hibino M; Hase R; Yamamoto M; Kasamatsu Y; Hirose M; Mutoh Y; Homma Y; Terada M; Ogawa T; Kashizaki F; Yokoyama T; Koba H; Kasahara H; Yokota K; Kato H; Yoshida J; Kita T; Kato Y; Kamio T; Kodama N; Uchida Y; Ikeda N; Shinoda M; Nakagawa A; Nakatsumi H; Horiguchi T; Iwata M; Matsuyama A; Banno S; Koseki T; Teramachi M; Miyata M; Tajima S; Maeki T; Nakayama E; Taniguchi S; Lim CK; Saijo M; Imai T; Yoshida H; Kabata D; Shintani A; Yuzawa Y; Kondo M
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958718
[TBL] [Abstract][Full Text] [Related]
19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
20. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
